SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001194396-06-000277
Filing Date
2006-08-31
Accepted
2006-08-30 19:10:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDED sc13d_62138.txt SC 13D/A 12747
2 REGISTRATION RIGHTS AGREEMENT ex1_62138.txt EX-1 90967
  Complete submission text file 0001194396-06-000277.txt   105786
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Subject) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: SC 13D/A | Act: 34 | File No.: 005-49893 | Film No.: 061066448
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GROSSFELD 10 ESCHEN N2 FL 9492
Business Address GROSSFELD 10 ESCHEN N2 FL 9492 423-79-17-066
ConPharm (Filed by) CIK: 0001369825 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N2 | Fiscal Year End: 1231
Type: SC 13D/A